Xtx Topco LTD Atai Life Sciences N.V. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.5 - $2.19 $124,687 - $182,043	83,125 Added 81.91%	184,612 $363,000
Q4 2023 Feb 13, 2024	SELL	$1.04 - $1.55 $78,471 - $116,952	-75,453 Reduced 42.64%	101,487 $143,000
Q3 2023 Nov 13, 2023	SELL	$1.27 - $2.28 $63,272 - $113,591	-49,821 Reduced 21.97%	176,940 $228,000
Q2 2023 Aug 14, 2023	SELL	$1.44 - $2.19 $161,269 - $245,264	-111,993 Reduced 33.06%	226,761 $390,000
Q1 2023 May 12, 2023	BUY	$1.17 - $2.7 $280,240 - $646,709	239,522 Added 241.38%	338,754 $613,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $236,172 - $352,273	99,232 New	99,232 $263,000
Q1 2022 May 13, 2022	SELL	$4.66 - $7.66 $82,864 - $136,210	-17,782 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.82 - $17.8 $121,273 - $316,519	17,782 New	17,782 $136,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.